What is the new opiate free drug? Introducing Journavx (Suzetrigine)
•
4 min read
In January 2025, the U.S. Food and Drug Administration (FDA) approved Journavx, marking the first new oral painkiller class in over two decades. The answer to **what is the new opiate free drug?** is this innovative medication, offering a significant and safer alternative for managing moderate-to-severe acute pain.
